Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
03/2003
03/27/2003WO2003025127A2 Chromogenic in situ hybridization methods, kits, and compositions
03/27/2003WO2003025119A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003WO2003025118A2 Multi-site mutagenesis
03/27/2003WO2003025117A2 Cloning and sequencing of pyruvate decarboxylase (pdc) genes from bacteria and uses therefor
03/27/2003WO2003025116A2 Method for increasing the solubility, expression rate and the activity of proteins during recombinant production
03/27/2003WO2003025019A1 Anti-pdgf antibodies and methods for producing engineered antibodies
03/27/2003WO2003025018A2 Dimeric and multimeric antigen binding structure
03/27/2003WO2003025016A2 Trk polypeptide purification method
03/27/2003WO2003025015A2 A soluble toll-like receptor
03/27/2003WO2003025011A1 Novel peptide, novel adsorbent, adsorption unit and adsorption method
03/27/2003WO2003025010A2 Human delta-n p73 molecules and uses thereof
03/27/2003WO2003025009A1 RECOMBINANT ALLERGEN WITH REDUCED IgE BINDING BUT UNDIMINISHED T-CELL ANTIGENICITY
03/27/2003WO2003025003A2 Hiv-gag codon-optimised dna vaccines
03/27/2003WO2003024999A2 THE F-BOX PROTEIN hCdc4 TARGETS CYCLIN E FOR UBIQUITINYLATION AND DEGRADATION
03/27/2003WO2003024992A2 HUMAN AND MOUSE β-DEFENSINS, ANTIMICROBIAL PEPTIDES
03/27/2003WO2003024991A2 Tall-1 receptor molecules and uses thereof
03/27/2003WO2003024988A1 Antisense modulation of nac expression
03/27/2003WO2003024987A1 Antisense modulation of fibroblast growth factor receptor 2 expression
03/27/2003WO2003024954A1 Novel terthiophene-3-carboxylic acid compound and fabricating method thereof, functionalized conductive terthiophene polymer with the compound as a monomer, process for dna hybridizatioon detection using the polymer, and fabricating method of probe dna
03/27/2003WO2003024502A2 Compositions and methods useful for non-invasive delivery of therapeutic molecules to the bloodstream
03/27/2003WO2003024406A2 Nestin-expressing hair follicle stem cells
03/27/2003WO2003024392A2 Compositions and methods for the diagnosis and treatment of tumor
03/27/2003WO2003024389A2 T. reesei phytase enyzmes, polynucleides encoding the enzymes, vectors and host cells thereof, and methods of using
03/27/2003WO2003024388A2 Methods and compositions for treating and preventing skin disorders using binding agents specific for psma
03/27/2003WO2003024386A2 Use of potent, selective and non toxic c-kit inhibitors for treating interstitial cystitis
03/27/2003WO2003024384A2 Improved methods for treatment with viral vectors
03/27/2003WO2003024308A2 Methods of assaying connective tissue growth factor
03/27/2003WO2003024200A2 Production of transgenic birds using stage x primordial germ cells
03/27/2003WO2003024199A2 Production of transgenic avians using sperm-mediated transfection
03/27/2003WO2003012090A3 Thermal tolerant avicelase from acidothermus cellulolyticus
03/27/2003WO2003004643A3 Reversed mammalian protein-protein interaction trap
03/27/2003WO2003000732A3 Fragments of the retinoic acid-related orphan receptor (ror) comprising the lig and binding domain (lbd), crystal structure of the lbd of ror-beta and their applications
03/27/2003WO2002098889A3 MAP3Ks AS MODIFIER OF THE p53 PATHWAY AND METHODS OF USE
03/27/2003WO2002098356A3 Ppp2cs as modifiers of the p53 pathway and methods of use
03/27/2003WO2002095033A3 Sequence of the tropheryma whippelii bacteria rpob gene and oligonucleotide for molecular diagnosis of whipple's disease
03/27/2003WO2002090551A3 Self-containing lactococcus strain
03/27/2003WO2002087496A3 Methods for inhibiting macrophage colony stimulating factor and c-fms-dependent cell signaling
03/27/2003WO2002085105A3 Tomato plants that exhibit resistance to $i(botrytis cinerea)
03/27/2003WO2002083888A3 The use of genes encoding abc transporters to stimulate the production of secondary metabolites in biological cells
03/27/2003WO2002083870A3 Pufa polyketide synthase systems and uses thereof
03/27/2003WO2002081650A3 Alcohol oxidase 1 regulatory nucleotide sequences for heterologous gene expression in yeast
03/27/2003WO2002079468A3 A method of increasing complementarity in a heteroduplex polynucleotide
03/27/2003WO2002079414A8 Transgenic mice containing clcn7 chloride channel gene disruptions
03/27/2003WO2002079403A9 Method for modifying plant biomass
03/27/2003WO2002079227A8 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002078607A3 Mucin peptide with immunoenhancing properties
03/27/2003WO2002077168A3 Mch1r deficient mice
03/27/2003WO2002074237A3 Compositions and methods for the therapy and diagnosis of kidney cancer
03/27/2003WO2002071834A3 Biotin-binding compounds for induction of sterility in plants
03/27/2003WO2002070717A3 Nitrile hydratase and a method for producing amides
03/27/2003WO2002070691A3 Abcg4 transporter and uses thereof
03/27/2003WO2002068927A3 Using viruses to detect or purify proteins
03/27/2003WO2002068587A3 Polynucleotide encoding a novel human potassium channel beta-subunit, k+betam3
03/27/2003WO2002064799A3 Optimized messenger rna
03/27/2003WO2002059291A3 Biological organism for preparing pharmaceutical compositions for treating mammals
03/27/2003WO2002059270A3 Methods and compositions for expressing polynucleotides specifically in smooth muscle cells in vivo
03/27/2003WO2002055992A3 Intrinsically fluorescent, self-multimerizing mhc fusion proteins and complexes thereof
03/27/2003WO2002055681A3 Regulation of human tau-tubulin kinase
03/27/2003WO2002053761A3 Recombinant protective protein from $i(streptococcus pneumoniae)
03/27/2003WO2002053717A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof
03/27/2003WO2002052019A3 22437, a human sulfatase and uses therefor
03/27/2003WO2002050271A3 Human ion channel protein and polynucleotides encoding the same
03/27/2003WO2002048358A3 Regulation of human chemokine-like receptor
03/27/2003WO2002046414A3 Human g-protein coupled receptor expressed highly in kidney
03/27/2003WO2002046403A3 Regulation of human patched-like protein
03/27/2003WO2002044377A3 Obp1:a protein selectively expressed in osteoblasts
03/27/2003WO2002044374A3 Flea gaba receptor subunit nucleic acid molecules, proteins and uses thereof
03/27/2003WO2002044195A3 Method for base sequencing and biologically active nucleic acids
03/27/2003WO2002040506A3 Modified clostridial neurotoxins with altered biological persistence
03/27/2003WO2002038777A3 Enzymes and encoding genes from methylophilus methylotrophus
03/27/2003WO2002038773A3 A human phospholipase c and uses thereof
03/27/2003WO2002036821A3 Method for the amplification and optional characterisation of nucleic acids
03/27/2003WO2002036633A3 Human 7tm proteins and polynucleotides encoding the same
03/27/2003WO2002034782A8 Endozepine-like polypeptide nov1 and nucleic acid encoding the same
03/27/2003WO2002034201A3 Use of pericyte apoptosis inhibitors for treating and/or preventing diabetic retinopathy
03/27/2003WO2002033086A3 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
03/27/2003WO2002033084A3 Identification of the dombrock blood group glycoprotein as a polymorphic member of the adp-ribosyltransferase gene family
03/27/2003WO2002031141A3 Antisense oligonucleotide directed toward mammalian vegf receptor genes and uses thereof
03/27/2003WO2002029071A3 Methods and compositions relating to the generation of partially transgenic organisms
03/27/2003WO2002029060A3 Hematopoietin receptors hpr1 and hpr2
03/27/2003WO2002026985A3 G-protein coupled recptors
03/27/2003WO2002026951A3 Oxidoreductases
03/27/2003WO2002024892A3 Isolated human g-protein coupled receptors, nucleic acid molecules encoding them, and uses thereof
03/27/2003WO2002024741A3 Isolated genomic polynucleotide fragments from chromosome 7
03/27/2003WO2002024640A3 Recombinant adenovirus vectors that are replication-competent in tert-expressing cells
03/27/2003WO2002022817A3 Nuclear receptor l66 and methods of use
03/27/2003WO2002022684A3 Transporters and ion channels
03/27/2003WO2002020050A9 Eiav p26 deletion vaccine and diagnostic
03/27/2003WO2002018573A3 54370, a novel human sulfate transporter and uses therefor
03/27/2003WO2002016642A9 Methods and compositions for directed molecular evolution using dna-end modification
03/27/2003WO2002016585A3 Imidazoline receptor homologs
03/27/2003WO2002016419A9 Progression suppressed gene 13 (psgen 13) and uses thereof
03/27/2003WO2002014560A9 Transfusion medicine leukodepletion filter devices as a source of genetic material for genotyping studies
03/27/2003WO2002012340A3 Transporters and ion channels
03/27/2003WO2002011667A3 Pharmaceutical compositions and methods useful for modulating angiogenesis
03/27/2003WO2002010445A2 Method for determining the age of individuals
03/27/2003WO2002009750A3 Vaccines for equine herpesvirus type-1: viruses harboring mutations within the immediate early gene
03/27/2003WO2002008411A3 Methods of creating dwarf phenotypes in plants
03/27/2003WO2002008394A3 23430, a novel human ubiquitin hydrolase family member and uses therefor
03/27/2003WO2002008259A3 Human cytokine receptor
1 ... 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 2569 2570 2571 2572 2573 2574 2575 2576 2577 ... 4023